Tofacitinib-d3 citrate

(Synonyms: Tasocitinib-d3 citrate; CP-690550-d3 citrate)
Kundenbewertung

Based on 1 Customer Validation

Tofacitinib-d3 citrate (Tasocitinib-d3 citrate; CP-690550-d3 citrate) is the deuterated-labeled Tofacitinib citrate (HY-40354A). Tofacitinib citrate (Tasocitinib citrate) is an orally active, blood-brain barrier permeable selective inhibitor of JAK1/JAK3. Tofacitinib citrate blocks the JAK-STAT/NF-κB signaling pathway, inhibits cytokine signal transduction, phosphorylation of STAT1/STAT5, and suppresses innate and adaptive immune responses. Tofacitinib citrate can be used in research related to major depressive disorder, rheumatoid arthritis, pulmonary diseases, systemic lupus erythematosus, and immune-mediated liver injury.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

  • Reinheit: 99.53%
  • CAS. Nr.: 2701680-77-3
  • Formel: C22H25D3N6O8
  • Molecular Weight:507.51
  • Speicherung:

    4°C, sealed storage, away from moisture

    * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

  • Biologische Aktivität
  • Chemical Information
  • Lösungsmittel & Löslichkeit
  • Reinheit & Dokumentation
  • Verweise
  • Help & FAQs

Alle JAK Isoform-spezifische Produkte anzeigen

More

Alle STAT Isoform-spezifische Produkte anzeigen

More

Alle NF-κB Isoform-spezifische Produkte anzeigen

More
MOQ
Minimum order quantity
100 mg

Angebot einholen Auf Lager

Other size
Angebot einholen
Please select quantity
Amount: USD 0.00